Response: Effects of 6 Months of Dapagliflozin Treatment on Metabolic Profile and Endothelial Cell Dysfunction for Obese Type 2 Diabetes Mellitus Patients without Atherosclerotic Cardiovascular Disease (J Obes Metab Syndr 2020;29:215-21)

• Ju-Young Hong,
• Keun-Young Park,
• Jong-Dai Kim,
• Won-Min Hwang,
• Dong-Mee Lim

Affiliations

Ju-Young Hong

Division of Endocrinology, Department of Internal Medicine, Konyang University College of Medicine, Daejeon, Korea

Keun-Young Park

Division of Endocrinology, Department of Internal Medicine, Konyang University College of Medicine, Daejeon, Korea

Jong-Dai Kim

Division of Endocrinology, Department of Internal Medicine, Konyang University College of Medicine, Daejeon, Korea

Won-Min Hwang

Division of Nephrology, Department of Internal Medicine, Konyang University College of Medicine, Daejeon, Korea

Dong-Mee Lim

Division of Endocrinology, Department of Internal Medicine, Konyang University College of Medicine, Daejeon, Korea